174 related articles for article (PubMed ID: 16838256)
1. [Pediatric neuro-oncology].
Navajas-Gutiérrez A
Rev Neurol; 2006 Jul 16-31; 43(2):88-94. PubMed ID: 16838256
[TBL] [Abstract][Full Text] [Related]
2. State of the art chemotherapeutic management of pediatric brain tumors.
Siegel MJ; Finlay JL; Zacharoulis S
Expert Rev Neurother; 2006 May; 6(5):765-79. PubMed ID: 16734524
[TBL] [Abstract][Full Text] [Related]
3. Advances in the treatment of pediatric brain tumors.
Rutka JT; Kuo JS; Carter M; Ray A; Ueda S; Mainprize TG
Expert Rev Neurother; 2004 Sep; 4(5):879-93. PubMed ID: 15853514
[TBL] [Abstract][Full Text] [Related]
4. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
[TBL] [Abstract][Full Text] [Related]
5. Brain tumors in children: a review.
Lacayo A; Farmer PM
Ann Clin Lab Sci; 1991; 21(1):26-35. PubMed ID: 2012378
[TBL] [Abstract][Full Text] [Related]
6. [A study group on brain tumors in childhood. Introduction, establishment and aims].
Kühl J
Klin Padiatr; 1987; 199(3):196-9. PubMed ID: 3626420
[TBL] [Abstract][Full Text] [Related]
7. Recent development in chemotherapy of paediatric brain tumours.
Grill J; Bhangoo R
Curr Opin Oncol; 2007 Nov; 19(6):612-5. PubMed ID: 17906461
[TBL] [Abstract][Full Text] [Related]
8. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
Papolos D; Mattis S; Golshan S; Molay F
J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
[TBL] [Abstract][Full Text] [Related]
9. [Use of chemotherapy in brain tumors in children--possibilities and perspectives].
Barjaktarević Z; Jeremić B; Sobić V
Srp Arh Celok Lek; 1989; 117(11-12):837-49. PubMed ID: 2491000
[TBL] [Abstract][Full Text] [Related]
10. Quantifying pediatric neuro-oncology risk factors: development of the neurological predictor scale.
Micklewright JL; King TZ; Morris RD; Krawiecki N
J Child Neurol; 2008 Apr; 23(4):455-8. PubMed ID: 18182641
[TBL] [Abstract][Full Text] [Related]
11. OMICS and brain tumour biomarkers.
Petrik V; Loosemore A; Howe FA; Bell BA; Papadopoulos MC
Br J Neurosurg; 2006 Oct; 20(5):275-80. PubMed ID: 17129872
[TBL] [Abstract][Full Text] [Related]
12. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
Brandes AA; Franceschi E; Tosoni A; Reni M; Gatta G; Vecht C; Kortmann RD
Crit Rev Oncol Hematol; 2009 Aug; 71(2):165-79. PubMed ID: 19303318
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology, clinical manifestations and supportive care of metastatic brain cancer.
Riva M; Landonio G; Arena O; Citterio A; Galli C; Ferrante E; Brioschi A; Collice M; Gambacorta M; Scialfa G; Defanti CA; Siena S
Forum (Genova); 2001; 11(1):4-26. PubMed ID: 11734861
[TBL] [Abstract][Full Text] [Related]
14. Molecular changes in brain tumors: prognostic and therapeutic impact.
Sanson M; Laigle-Donadey F; Benouaich-Amiel A
Curr Opin Oncol; 2006 Nov; 18(6):623-30. PubMed ID: 16988585
[TBL] [Abstract][Full Text] [Related]
15. [Bilateral thalamic tumours. Three case reports and a review of the literature].
Gelabert-González M; Seramito-García R; Bandín-Diéguez J; Allut AG
Rev Neurol; 2007 Nov 16-30; 45(10):599-603. PubMed ID: 18008265
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management of pediatric central nervous system tumors.
Abdullah S; Qaddoumi I; Bouffet E
Ann N Y Acad Sci; 2008 Sep; 1138():22-31. PubMed ID: 18837879
[TBL] [Abstract][Full Text] [Related]
17. Current treatment approaches for infants with malignant central nervous system tumors.
Lafay-Cousin L; Strother D
Oncologist; 2009 Apr; 14(4):433-44. PubMed ID: 19342475
[TBL] [Abstract][Full Text] [Related]
18. [Central nervous system tumours in childhood: their clinical pathological aspects].
Ortega Aznar A; Romero Vidal FJ
Rev Neurol; 2004 Mar 16-31; 38(6):554-64. PubMed ID: 15054721
[TBL] [Abstract][Full Text] [Related]
19. [Imidazoline I(2) receptors as a possible marker for malignancy in human glial cell tumours].
Callado LF; Garibi JM; Meana JJ
Rev Neurol; 2006 Oct 16-31; 43(8):476-80. PubMed ID: 17033981
[TBL] [Abstract][Full Text] [Related]
20. [Perspectives in diagnosis and management of malignant gliomas].
Psimaras D; Delattre JY
Cancer Radiother; 2008 Nov; 12(6-7):695-700. PubMed ID: 18829366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
